Global AMR R&D HUB / Our Work / Expert Advisory Group

Expert Advisory Group

The Expert Advisory Group evaluates the market potential of diagnostic, preventive and therapeutic interventions, focused on the WHO priority pathogen list and tuberculosis, supporting discussions on incentives for AMR R&D investments.

The Expert Advisory Group comprises fourteen members and two ex-officio members (OECD, WHO) with expertise across human, animal, and environmental health sectors.

Funded by:
Federal Ministry of Health
Federal Ministry of Education and Research